A Path Forward for Understanding and Addressing Multifaceted Pancreatic Cancer Disparities.
作者信息
Permuth Jennifer B, Powers Benjamin D, Hodul Pamela J
机构信息
Department of Gastrointestinal Oncology and, Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
Department of Gastrointestinal Oncology and, Department of Health Outcomes and Behavior, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
出版信息
Gastroenterology. 2022 Jul;163(1):51-53. doi: 10.1053/j.gastro.2022.04.047. Epub 2022 May 2.
Abstract
摘要
相似文献
1
A Path Forward for Understanding and Addressing Multifaceted Pancreatic Cancer Disparities.理解和解决多方面胰腺癌差异的前进道路。
Gastroenterology. 2022 Jul;163(1):51-53. doi: 10.1053/j.gastro.2022.04.047. Epub 2022 May 2.
2
Health Care Disparities and the Future of Pancreatic Cancer Care.医疗保健差异与胰腺癌护理的未来。
Surg Oncol Clin N Am. 2021 Oct;30(4):759-771. doi: 10.1016/j.soc.2021.06.012.
3
ASO Author Reflections: Addressing Racial Disparities in Pancreatic Cancer: How Can We Do Better?《美国外科医师学会杂志》作者反思：解决胰腺癌中的种族差异问题：我们如何才能做得更好？
Ann Surg Oncol. 2023 Apr;30(4):2482-2483. doi: 10.1245/s10434-023-13110-5. Epub 2023 Jan 18.
4
Diversity and Inclusion in Pancreatic Cancer Clinical Trials.胰腺癌临床试验中的多样性与包容性。
Gastroenterology. 2021 Dec;161(6):1741-1746.e3. doi: 10.1053/j.gastro.2021.06.079. Epub 2021 Aug 17.
5
Calling Out Disparities in Pancreatic Cancer Care.指出胰腺癌治疗中的差异。
JAMA Surg. 2023 Mar 1;158(3):292. doi: 10.1001/jamasurg.2022.6720.
6
Undertreatment of Pancreatic Cancer: The Intersection of Bias, Biology, and Geography.胰腺癌治疗不足：偏见、生物学和地理学的交集。
Surg Oncol Clin N Am. 2022 Jan;31(1):43-54. doi: 10.1016/j.soc.2021.07.006. Epub 2021 Oct 19.
7
Changing before we have to; how to mitigate disparities in pancreatic cancer care?在不得不改变之前做出改变；如何缩小胰腺癌治疗方面的差距？
Acta Oncol. 2022 Mar;61(3):275-276. doi: 10.1080/0284186X.2022.2041720. Epub 2022 Feb 16.
8
Pancreas cancer in Mississippi: present challenges and future directions.密西西比州的胰腺癌：当前挑战与未来方向。
J Miss State Med Assoc. 2010 Apr;51(4):99-103.
9
Disparities in access to health care system as determinant of survival for patients with pancreatic cancer in the State of São Paulo, Brazil.巴西圣保罗州胰腺癌患者生存状况受医疗保健系统可及性差异的影响。
Sci Rep. 2021 Mar 18;11(1):6346. doi: 10.1038/s41598-021-85759-5.
10
Disparities in utilization of treatment for clinical stage I-II pancreatic adenocarcinoma by area socioeconomic status and race/ethnicity.按地区社会经济地位和种族/民族划分的临床 I-II 期胰腺腺癌治疗利用的差异。
Surgery. 2019 Apr;165(4):751-759. doi: 10.1016/j.surg.2018.10.035. Epub 2018 Dec 11.
引用本文的文献
1
Comprehensive age-period-cohort analysis of global pancreatitis burden and socioeconomic disparities (1990-2021).全球胰腺炎负担及社会经济差异的综合年龄-时期-队列分析（1990 - 2021年）
BMC Gastroenterol. 2025 Sep 1;25(1):630. doi: 10.1186/s12876-025-04222-1.
2
A sex dependent association between the history of autoimmune disease and the development of pancreatic cancer: a case-control study of 32,640 patients.自身免疫性疾病史与胰腺癌发生之间的性别依赖性关联：一项对32640例患者的病例对照研究。
Front Oncol. 2025 Jul 8;15:1613787. doi: 10.3389/fonc.2025.1613787. eCollection 2025.
3
CD71 expressing circulating neutrophils serve as a novel prognostic biomarker for metastatic spread and reduced outcome in pancreatic ductal adenocarcinoma patients.表达 CD71 的循环中性粒细胞可作为胰腺导管腺癌患者转移扩散和预后降低的新型预后生物标志物。
Sci Rep. 2024 Sep 10;14(1):21164. doi: 10.1038/s41598-024-70916-3.
本文引用的文献
1
Rising Incidence and Racial Disparities of Early-Onset Pancreatic Cancer in the United States, 1995-2018.1995 - 2018年美国早发性胰腺癌发病率上升及种族差异
Gastroenterology. 2022 Jul;163(1):310-312.e1. doi: 10.1053/j.gastro.2022.03.011. Epub 2022 Mar 11.
2
Racial Disparity Between Whites and African Americans in Incidence and Outcome of Pancreatic Cancer: Have We Made a Difference?白人和非裔美国人在胰腺癌发病率和预后方面的种族差异：我们有何进展？
Gastroenterology. 2022 Apr;162(4):1346-1348.e3. doi: 10.1053/j.gastro.2021.12.256. Epub 2021 Dec 18.
3
Incidence of Pancreatic Cancer by Age and Sex in the US, 2000-2018.美国 2000-2018 年按年龄和性别划分的胰腺癌发病率。
JAMA. 2021 Nov 23;326(20):2075-2077. doi: 10.1001/jama.2021.18859.
4
Diversity and Inclusion in Pancreatic Cancer Clinical Trials.胰腺癌临床试验中的多样性与包容性。
Gastroenterology. 2021 Dec;161(6):1741-1746.e3. doi: 10.1053/j.gastro.2021.06.079. Epub 2021 Aug 17.
5
Treatment patterns and survival in patients with early-onset pancreatic cancer.早发性胰腺癌患者的治疗模式和生存情况。
Cancer. 2021 Oct 1;127(19):3566-3578. doi: 10.1002/cncr.33664. Epub 2021 Jul 6.
6
Early-Onset Pancreas Cancer: Clinical Descriptors, Genomics, and Outcomes.早发性胰腺癌：临床特征、基因组学和预后。
J Natl Cancer Inst. 2021 Sep 4;113(9):1194-1202. doi: 10.1093/jnci/djab038.
7
The Florida Pancreas Collaborative Next-Generation Biobank: Infrastructure to Reduce Disparities and Improve Survival for a Diverse Cohort of Patients with Pancreatic Cancer.佛罗里达胰腺协作下一代生物样本库：减少差异并提高不同胰腺癌患者群体生存率的基础设施。
Cancers (Basel). 2021 Feb 15;13(4):809. doi: 10.3390/cancers13040809.
8
Cancer Statistics, 2021.癌症统计数据，2021.
CA Cancer J Clin. 2021 Jan;71(1):7-33. doi: 10.3322/caac.21654. Epub 2021 Jan 12.
9
Delving into Early-onset Pancreatic Ductal Adenocarcinoma: How Does Age Fit In?深入研究早发性胰腺导管腺癌：年龄因素如何影响？
Clin Cancer Res. 2021 Jan 1;27(1):246-254. doi: 10.1158/1078-0432.CCR-20-1042. Epub 2020 Sep 21.
10
Pharmacologic Activation of the G Protein-Coupled Estrogen Receptor Inhibits Pancreatic Ductal Adenocarcinoma.激动 G 蛋白偶联雌激素受体抑制胰腺导管腺癌。
Cell Mol Gastroenterol Hepatol. 2020;10(4):868-880.e1. doi: 10.1016/j.jcmgh.2020.04.016. Epub 2020 May 4.
Zotero 插件